Care is only as accurate as the data it\u2019s based on<\/p>\n
HHS Secretary Robert F. Kennedy Jr.\u2019s call for widespread public adoption of wearable healthcare technologies preceded the White House\u2019s July announcement of a new private health tracking system. The program, slated to launch early next year, would facilitate the upload of medical records into systems and apps run by private tech companies<\/a>. While the idea of placing more emphasis on data to improve care is laudable, true improvements are reliant on accurate, trustworthy information. Basing decisions, research initiatives or policy development on unreliable or erroneous data will only lead to ineffective care and programs.\u00a0<\/p>\n The degree of accuracy associated with wearable-generated health data can vary widely depending on the device, the wearer, and the type of metric. The devices may offer useful trend data, but raw data isn\u2019t always dependable. Often, the information provided probably isn\u2019t something on which the wearer would want a physician to base treatments or a care plan. Apple\u2019s recent announcement that the new Apple Watch will notify users of concerning high blood pressure patterns<\/a> over a 30-day period shows the company is moving closer to true medical-grade wearables by first addressing consumer awareness. This \u201cconcerning trend\u201d alert would, in theory, prompt users to monitor their blood pressure at home or schedule an assessment with their medical provider.\u00a0\u00a0\u00a0<\/p>\n I occasionally use the ECG app on my smartwatch to monitor my heart rate and rhythm. Despite activating it correctly, I\u2019ve found it\u2019s not unusual to receive inaccurate readings caused by poor signal quality. As a physician, I understand the nuances and implications behind these readings, so I don\u2019t find inconclusive results as concerning as someone outside of healthcare might. For users without a medical background, such readings could be unsettling and may even prompt an unnecessary trip to the hospital \u2014 only to be told that smartwatch data should be interpreted with caution. Technology should enhance, not replace, professional care. In this sense, consumer-focused technology is an \u201cand,\u201d not an \u201cor.\u201d<\/p>\n Wearables play an important role in wellness and lifestyle improvements<\/p>\n Though not intended for use as a medical-grade device, wearables are excellent for tracking wellness metrics and contributing to healthy lifestyle changes. A Journal of Medical Internet Research study found that 64% of users reported improved health outcomes when they utilized data insights provided by their devices<\/a>. Any improvement in health is beneficial, so if a smartwatch proves useful in maintaining a fitness routine and a balanced lifestyle, then it\u2019s worth the personal investment.<\/p>\n When used for their intended purposes, wearables offer many advantages. And while they do generate enormous amounts of health data, it\u2019s still not reliable or standardized enough to stand alone as a tool for managing chronic disease. Substantial progress has been made, though, thanks to the development of policies like the 21st Century Cures Act, which required greater interoperability across EHRs <\/a>so patients could more easily access their own data. However, those regulations applied to clinical systems and didn\u2019t extend to data from other channels, like consumer apps and devices.\u00a0<\/p>\n Similarly, the \u201cKill the Clipboard\u201d roadmap unveiled in July is intended to modernize data exchange<\/a> by eliminating paper forms and manual data collection. This effort to facilitate the seamless storage and accessibility of patient data emphasizes the use of digital-first workflows and interoperability, building on Cures Act provisions such as mandating standardized APIs and prohibiting information blocking. Initiatives like these lay the foundation for consumer-generated data to eventually flow into clinical systems in a way that\u2019s usable and compliant. Patients stand to benefit from the convenience these changes would afford, but it shouldn\u2019t come at the expense of patient privacy and security.<\/p>\n Use of data collection for research must not compromise trust and privacy<\/p>\n There\u2019s no question that large datasets are essential to advance medical research and answer critical health questions. Leveraging the insights responsibly helps to identify trends, improve public health responses, and speed the development of new treatments. However, patient trust hinges on transparency into how that data is collected, stored and shared. Everyone deserves the confidence of knowing their information is being handled ethically. The collaborative element of the administration\u2019s new health tracking system could improve data flow, but concerns around privacy, consent, and potential misuse make it difficult to determine whether the benefits outweigh the risks.<\/p>\n To shift wearables from wellness tools to useful drivers of disease management, the data they generate must be as trustworthy as it is plentiful. Clear frameworks that govern how information is gathered and used are needed, along with standards for the accuracy and reliability of devices. Interoperability rules, like those already in place for certified medical devices, should apply to all consumer health technologies. Safeguarding data with strong privacy protections is fundamental to maintaining patient trust, which is the top priority at all times. The future of healthcare technology is brightest when innovation is combined with evidence to build systems that strengthen \u2014 not strain \u2014 relationships between patients and their providers.\u00a0<\/p>\n As a supplement to comprehensive care, wearables can absolutely contribute to better wellness, but they won\u2019t be the sole determining factor. Fully integrating the devices into care delivery is possible, but will require time and a firm commitment from the healthcare and tech industries to establish standards that verify the reliability of wearables and the data generated.<\/p>\n Photo: LDProd, Getty Images<\/p>\n Lucienne Marie Ide, M.D., PH.D.<\/a>, is the founder and Chief Executive Officer of Rimidi<\/a>, a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. She brings her diverse experiences in medicine, science, venture capital, and technology to bear in leading Rimidi\u2019s strategy and vision. Motivated by the belief that we can do so much better as individuals, in industry, and in society. After completing her internship in Obstetrics and Gynecology at UPMC, Dr. Ide left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.<\/p>\n![\"Avatar](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2025\/11\/Lucie-Ide-150x150.jpeg\")
<\/a><\/p>\n